Neumora

📍 Watertown, United States🗓 Founded 2020👥 123 employees💰 Last funded Sep 2021
Biotechnology Research🌐 neumoratx.com
Website LinkedIn
Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people. However, treatments for many of the most prevalent brain disorders have been dominated by a single class of drugs, such as serotonin targeting antidepressants for MDD, leaving patients with a high degree of unmet medical need given the lack of diverse treatment options and mechanisms of action. We are taking a fundamentally different approach to the way treatments for brain diseases are developed. Our pipeline is comprised of programs pursuing therapeutically relevant targets implicated in Central Nervous System (CNS) diseases, each targeting a novel mechanism of action with best-in-class pharmacology. Our work is supported by our Precision Toolbox, which integrates a suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora is relentless in its commitment to discovering, developing and commercializing novel therapies for the 1.5 billion people living with brain diseases.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2020–2021 · investors recorded per year
2020120212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Neumora?
Neumora has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Neumora last raise funding?
The most recent investment in Neumora recorded on gritt.io was in September 2021.
When was Neumora founded?
Neumora was founded in 2020.
What industry is Neumora in?
Neumora operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neumora based?
Neumora is headquartered in Watertown, United States.